Tulsa, Oklahoma-based healthtech startup Menovē, founded by former risk management analyst Aujena DuPree, is tackling the systemic friction of perimenopause care by turning erratic daily symptoms into clinically structured data.
Tulsa, Oklahoma-based healthtech startup Menovē, founded by former risk management analyst Aujena DuPree, is tackling the systemic friction of perimenopause care by turning erratic daily symptoms into clinically structured data. By acting as an analytical translation layer between patients and physicians during the typical three-month gaps between appointments, the app’s correlation engine helps users surface 72% more valid health concerns to eliminate diagnostic guesswork. Backed by strong early validation—including a 50% waitlist conversion rate—the company utilizes a direct-to-consumer model with a $96 blended ARPU, targeting a $144,000 Year 1 ARR milestone as it raises a $250,000 round to anchor its position in a $1 billion addressable market.